Pharmacies are a potential site for access to sterile syringes as a means for preventing human immunodeficiency virus (HIV), but the type and extent of their utility is uncertain. To examine pharmacy syringe purchase, we conducted a standardized, multistate study in urban and rural areas of four states in which attempts to purchase syringes were documented. Of 1,600 overall purchase attempts, 35% were refused.
View Article and Find Full Text PDFJ Am Pharm Assoc (Wash)
January 2003
Objective: To examine pharmacists' attitudes and practices surrounding human immunodeficiency virus (HIV) prevention among injection drug users.
Design: Focus groups.
Setting: Urban and rural sites in Colorado, Connecticut, Kentucky, and Missouri.